Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | |
| Sales | 201,037 |
| Total expenses | 58,283 |
| Operating Income | 142,754 |
| Interest Expense | 8,286 |
| Other Income | -81,535 |
| Pre-tax Income | 52,933 |
| Income Tax | 23,899 |
| Net Income Continuous | 29,034 |
| Net Income | $29,034 |
| EPS Basic Continuous Ops | 0.72 |
| EPS Basic Total Ops | 0.72 |
| EPS Diluted Continuous Ops | 0.72 |
| EPS Diluted Total Ops | 0.72 |
| EBITDA(a) | $148,102 |